Qualigen Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/14/2022 | 1.03 M | $274,000 | 0.00% | 2.60% |
| BLACKROCK INC. | 11/14/2022 | 258,419 | $69,000 | 0.00% | 0.66% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/14/2022 | 226,671 | $60,000 | 0.00% | 0.57% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2022 | 128,900 | $35,000 | 0.00% | 0.33% |
| STATE STREET CORP | 11/15/2022 | 109,314 | $29,000 | 0.00% | 0.28% |
| HIGHMARK WEALTH MANAGEMENT LLC | 10/21/2022 | 80,094 | $21,000 | 0.00% | 0.20% |
| UBS GROUP AG | 11/10/2022 | 56,777 | $16,000 | 866.25% | 0.14% |
| FRANKLIN RESOURCES INC | 11/14/2022 | 55,448 | $15,000 | 0.00% | 0.14% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 10/25/2022 | 48,641 | $13,000 | 0.00% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 11/14/2022 | 47,960 | $13,000 | 36.91% | 0.12% |
| NORTHERN TRUST CORP | 11/14/2022 | 43,253 | $12,000 | 0.00% | 0.11% |
| WEDBUSH SECURITIES INC | 10/18/2022 | 32,228 | $9,000 | 0.00% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2022 | 22,900 | $6,000 | -62.46% | 0.06% |
| KESTRA ADVISORY SERVICES, LLC | 11/01/2022 | 20,000 | $5,000 | 0.00% | 0.05% |
| CRA FINANCIAL SERVICES, LLC | 10/24/2022 | 19,957 | $5,000 | 0.00% | 0.05% |
| BANK OF NEW YORK MELLON CORP | 11/14/2022 | 18,879 | $5,000 | 0.00% | 0.05% |
| GROUP ONE TRADING, L.P. | 11/09/2022 | 18,247 | $5,000 | 0.00% | 0.05% |
| RENAISSANCE TECHNOLOGIES LLC | 11/14/2022 | 14,500 | $4,000 | 100.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/10/2022 | 13,253 | $4,000 | 43.66% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2022 | 12,100 | $3,000 | -71.93% | 0.03% |
| US BANCORP \DE\ | 10/27/2022 | 8,243 | $2,000 | 0.00% | 0.02% |
| RETIREMENT GROUP, LLC | 11/14/2022 | 3,500 | $1,000 | 100.00% | 0.01% |
| SIMPLEX TRADING, LLC | 11/04/2022 | 536 | $0 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/14/2022 | 258 | $0 | 18.89% | 0.00% |
| GLASSMAN WEALTH SERVICES | 11/09/2022 | 200 | $0 | 0.00% | 0.00% |
| GUARDIAN WEALTH ADVISORS, LLC | 11/09/2022 | 200 | $0 | 100.00% | 0.00% |
| ARCHER INVESTMENT CORP | 11/09/2022 | 160 | $43 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2022 | 48 | $0 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2022 | 11 | $0 | 1,000.00% | 0.00% |
| IFP ADVISORS, INC | 11/08/2022 | 1 | $1,000 | 0.00% | 0.00% |
| CREDIT SUISSE AG/ | 11/10/2022 | 1 | $0 | 0.00% | 0.00% |
| ATLAS CAPITAL ADVISORS LLC | 11/08/2022 | 1 | $0 | 100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 11/15/2022 | 0 | $0 | 0.00% | 0.00% |
| CREATIVE PLANNING | 11/03/2022 | 0 | $0 | -100.00% | 0.00% |
| SOLTIS INVESTMENT ADVISORS LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 11/13/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Qualigen Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Qualigen Therapeutics, Inc.. The most heavily invested institutionals were:
HATTON CONSULTING, INC.: 27,195
QS Investors, LLC: 82,000
5.66% of Qualigen Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 109,195 shares in the last 24 months. This purchase volume represents approximately $492,469 in transactions.